EUVIMED · CrossrefJournal
Expert Opinion on Drug Metabolism & Toxicology
ISSN 1742-5255 · Informa UK Limited
Latest articles
Pembrolizumab plus lenvatinib in advanced endometrial cancer: pharmacology, efficacy, safety and future perspectives
Machine learning prediction of cyclosporine nephrotoxicity in pediatric patients using therapeutic drug monitoring and clinical data
Practical considerations for the safe use of pembrolizumab or durvalumab plus gemcitabine and cisplatin in advanced biliary tract Cancer
Artificial intelligence support for the prediction and management of drug-drug interactions
Amino acids for the treatment of Parkinson’s disease: beyond levodopa
Understanding pharmacokinetics of novel prolonged release dienogest 2 mg / ethinyl-estradiol 0.02 mg oral contraceptive formulation: clinical applications
Population pharmacokinetic models for unbound mycophenolic acid
Maternal–placental–fetal physiologically based pharmacokinetic modeling: current approaches and future perspectives
Vepdegestrant (ARV-471): pharmacokinetics, drug metabolism and clinical translation of an oral ERα-targeting PROTAC
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
Drug-drug interactions in patients living with HIV and major depression
Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines Biobank and Cohort study
How can we overcome the pharmacokinetic challenges posed when conducting complex DDI studies?
Clinical, toxicological and pharmacokinetic data of emerging drugs for the treatment of atherosclerosis: are they promising?
Citalopram serum concentrations in men and women of pre- and post-menopausal age
Evaluation of the pharmacokinetics of emerging therapeutics for high grade glioma
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
Transplacental pharmacokinetics and developmental toxicity of chemotherapeutic agents: a comparative analysis of fetal and pediatric exposure profiles
Gastrointestinal bleeding risk among antithrombotics users: a propensity score matched study of drug classes
Predicting the potential for organic cation transporter 1-mediated drug–drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil
New insights into the role of CYP26 in retinoic acid clearance
Rethinking pharmacokinetics in preterm and term neonates and infants: sex as a critical biological variable
Exploring the influence of sex on idiosyncratic DILI: impact on risk assessment
Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations
Pregnancy and epilepsy: pharmacokinetic insights into antiseizure medications
Microbiome-driven PKs: addressing research gaps and shaping future directions beyond the narrative review
An update on the pharmacokinetic and pharmacodynamic interactions between antidepressants and antiseizure medications
EUVIMED